The Asia Pacific Intraocular Lens Market is expected to witness market growth of 5.0% CAGR during the forecast period (2021-2027).
Utilizing a specific variety of premium IOL in every eye might sometimes provide in the greatest visual results following cataract surgery. One eye may have higher astigmatism than the other, for instance. If that's the case, a cataract surgeon might suggest a toric IOL in that eye, as well as an adapting IOL in the other, to eliminate necessity computer glasses. Some other possibility is that the cataract surgeon will propose one type of multifocal lens for one eye and another for the other. This is due to the fact that one brand may give superior computer vision while the other may provide clearer vision at a closer range, such as when reading or performing other close-up jobs.
The significant growth rate of the region is primarily attributable to reasons such as a rise in international patient migration to Asian nations that provide low-cost treatment, increased market penetration in developed nations, and government initiatives that promote ophthalmic care. The Indian National Blindness and Visual Impairment Control System was established in order to raise awareness and provide comprehensive cataract eye care services, as well as refractive errors, corneal problems, and glaucoma treatment. Medical tourists are also attracted by a number of factors, including favourable exchange rates and access to high-quality care at an affordable cost.
China and India are expected to expand at the fastest rates in the Asia-Pacific area. Some of the primary driving factors for the Intraocular Lens Market in developing countries include government actions to incorporate eye care into social security systems, a rise in the geriatric population, an upsurge in cataract cases, and an anticipated increment in the diabetic population. Because of the increased incidence of diabetes and cataracts in Asia Pacific, the market is expected to grow.
The China market dominated the Asia Pacific Intraocular Lens Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $412.9 Million by 2027. The Japan market is poised to grow at a CAGR of 4.4% during (2021 - 2027). Additionally, The India market is expected to experience a CAGR of 5.7% during (2021 - 2027).
Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, Eye Research Institutes, and Ambulatory Surgery Centers. Based on Product, the market is segmented into Multifocal, Monofocal, Toric, and Accommodative. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Rayner Intraocular Lenses Limited, Bausch Health Companies, Inc., Carl Zeiss AG, Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Hoya Corporation, and Alcon, Inc.
By End-Use
By Product
By Country
Utilizing a specific variety of premium IOL in every eye might sometimes provide in the greatest visual results following cataract surgery. One eye may have higher astigmatism than the other, for instance. If that's the case, a cataract surgeon might suggest a toric IOL in that eye, as well as an adapting IOL in the other, to eliminate necessity computer glasses. Some other possibility is that the cataract surgeon will propose one type of multifocal lens for one eye and another for the other. This is due to the fact that one brand may give superior computer vision while the other may provide clearer vision at a closer range, such as when reading or performing other close-up jobs.
The significant growth rate of the region is primarily attributable to reasons such as a rise in international patient migration to Asian nations that provide low-cost treatment, increased market penetration in developed nations, and government initiatives that promote ophthalmic care. The Indian National Blindness and Visual Impairment Control System was established in order to raise awareness and provide comprehensive cataract eye care services, as well as refractive errors, corneal problems, and glaucoma treatment. Medical tourists are also attracted by a number of factors, including favourable exchange rates and access to high-quality care at an affordable cost.
China and India are expected to expand at the fastest rates in the Asia-Pacific area. Some of the primary driving factors for the Intraocular Lens Market in developing countries include government actions to incorporate eye care into social security systems, a rise in the geriatric population, an upsurge in cataract cases, and an anticipated increment in the diabetic population. Because of the increased incidence of diabetes and cataracts in Asia Pacific, the market is expected to grow.
The China market dominated the Asia Pacific Intraocular Lens Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $412.9 Million by 2027. The Japan market is poised to grow at a CAGR of 4.4% during (2021 - 2027). Additionally, The India market is expected to experience a CAGR of 5.7% during (2021 - 2027).
Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, Eye Research Institutes, and Ambulatory Surgery Centers. Based on Product, the market is segmented into Multifocal, Monofocal, Toric, and Accommodative. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Rayner Intraocular Lenses Limited, Bausch Health Companies, Inc., Carl Zeiss AG, Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Hoya Corporation, and Alcon, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End-Use
- Hospitals
- Ophthalmic Clinics
- Eye Research Institutes
- Ambulatory Surgery Centers
By Product
- Multifocal
- Monofocal
- Toric
- Accommodative
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- EyeKon Medical, Inc.
- Lenstec, Inc.
- HumanOptics AG
- STAAR Surgical Company
- Rayner Intraocular Lenses Limited
- Bausch Health Companies, Inc.
- Carl Zeiss AG
- Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
- Hoya Corporation
- Alcon, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Intraocular Lens Market by End-use
Chapter 5. Asia Pacific Intraocular Lens Market by Product
Chapter 6. Asia Pacific Intraocular Lens Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- EyeKon Medical, Inc.
- Lenstec, Inc.
- HumanOptics AG
- STAAR Surgical Company
- Rayner Intraocular Lenses Limited
- Bausch Health Companies, Inc.
- Carl Zeiss AG
- Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
- Hoya Corporation
- Alcon, Inc.
Methodology
LOADING...
